Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Scalp melanoma is more common and easier to diagnose early in people with androgenetic alopecia due to sun damage.

Male pattern baldness, especially the vertex type, could be an early sign of cardiovascular risk factors like high cholesterol and diabetes.

Proper medical treatments can control and even reverse female pattern hair loss, but it's important to check for related conditions like excessive male hormone production, especially in severe cases.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

The document concludes that more research is needed to understand hair loss in men and to find new treatments.

Topical finasteride is promising for hair loss with minimal side effects but needs more research and approval.

The new topical product combined with finasteride significantly increased hair thickness without side effects.

The conclusion is that a safe donor area for hair transplants varies and should be chosen based on individual factors like race, future hair loss, family history, and specific thinning patterns.

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

Vitamin D deficiency is common in people with certain types of hair loss, like alopecia areata and female pattern hair loss.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.

Low-dose oral minoxidil may help treat hair loss but is not FDA-approved and can cause side effects like unwanted hair growth and heart issues.

Hair aging and loss are caused by genetics, hormones, environment, and grooming, with treatments like minoxidil effective for certain types of hair loss.

Male pattern baldness is mainly caused by genetics and hormones, treatable with minoxidil and finasteride.

New treatments for male pattern hair loss look promising, but established treatments are still the main option.

DNA can predict physical traits like eye and hair color accurately, especially in Europeans, but predicting other traits and in diverse populations needs more research.

Testosterone causes hair loss in AGA mice, which are good for testing baldness treatments, and both minoxidil and cyproterone acetate can prevent this hair loss.

A woman with Degos disease managed her condition for nine years with medications and had two healthy pregnancies, while a separate finding suggests a possible link between female pattern hair loss and high blood pressure.

Hair loss can be treated with common methods like minoxidil and finasteride, but new potential treatments include growth factors, cytokines, and platelet-rich plasma injections.

AGA is caused by genetics and androgens, treatable with finasteride and minoxidil.

Androgenetic alopecia causes hair loss by shrinking hair follicles due to androgens, with the connection between the muscle and hair follicle determining if the loss is reversible.

Men with early hair loss and hormonal changes like PCOS could be the male equivalent of PCOS, not linked to metabolic syndrome.

Practitioners treating hair loss need better education and resources to overcome challenges like commercial bias and ethical dilemmas.

Modern hair restoration surgery has advanced greatly since 1959.

Oral minoxidil may be a better treatment for hair loss than topical minoxidil.

Understanding hair follicle biology and stem cell control could lead to new hair loss treatments.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Androgenetic alopecia negatively affects quality of life and self-esteem, especially in women, but not depression.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.